Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Capricor's treatment for cardiomyopathy met its late-stage goals Capricor Therapeutics Inc (NASDAQ:CAPR) is one of the best stocks on Wall Street today, up 263% to trade at $23.09, after the biotech ... Get real-time Capricor Therapeutics Inc (CAPR) stock price, news, financials, community insights, and trading ideas.

Understanding the Context

Join 10 million+ investors and traders tracking markets in real-time on Stocktwits. Find the latest Capricor Therapeutics, Inc. (CAPR) stock quote, history, news and other vital information to help you with your stock trading and investing. CAPR | Complete Capricor Therapeutics Inc.

Key Insights

stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. CAPR Stock Price | Capricor Therapeutics Inc. Stock Quote (U.S.: Nasdaq ... Get the latest Capricor Therapeutics Inc (CAPR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Final Thoughts

Shares of Capricor Therapeutics (CAPR) jumped 1% in premarket trading on Tuesday after reports said a former company executive is being considered to lead the FDA’s top gene therapy division ... CAPR stock gains steam: Former Capricor exec could become FDA’s ... - MSN Capricor Therapeutics Inc. research and ratings by Barron's. View CAPR revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. (NASDAQ: CAPR) Capricor Therapeutics trades on the NASDAQ under the ticker symbol CAPR.

Capricor Therapeutics stock quotes can also be displayed as NASDAQ: CAPR. If you're new to stock investing, here's how to buy Capricor Therapeutics stock. What is the 52 week high and low for Capricor Therapeutics (NASDAQ: CAPR)? Discover real-time Capricor Therapeutics, Inc.